- By Connolly Steigerwald, MS, CGC
- Posted May 5, 2026
The Gene Scene: MYBPC3
Welcome to the Gene Scene! Each week, we will explore a gene from the ACMG Secondary Findings list—genes identified by the American College of Medical Genetics and Genomics as having clear, actionable health implications. These genes are included because they’re linked to serious but preventable or manageable conditions when identified early.…
- By Bradley Power, MS, CGC
- Posted April 28, 2026
The Gene Scene: RYR1
Welcome to the Gene Scene! Each week, we will explore a gene from the ACMG Secondary Findings list—genes identified by the American College of Medical Genetics and Genomics as having clear, actionable health implications. These genes are included because they’re linked to serious but preventable or manageable conditions when identified early.…
- By Heather Fecteau, MS, CGC
- Posted April 27, 2026
Empowered Patients Start with Better Education
Patient autonomy sounds big and formal, but at its core it’s simple: People should understand their options so they can make choices that feel right for them. The Ambry CARE Program® (CARE) believes patients make better decisions when they understand their options. That’s why education is built directly into the CARE experience, designed…
- By Sarah Campian, MS, CGC
- Posted April 21, 2026
The Gene Scene: TMEM127
Welcome to the Gene Scene! Each week, we will explore a gene from the ACMG Secondary Findings list—genes identified by the American College of Medical Genetics and Genomics as having clear, actionable health implications. These genes are included because they’re linked to serious but preventable or manageable conditions when identified early.…
- By Sarah Campian, MS, CGC
- Posted April 16, 2026
Leading the Shift to Proactive Care: The Christ Hospital’s High‑Risk Program Strategy
In the traditional healthcare model, cancer care is often reactive—a race against time that begins only after a diagnosis. But at The Christ Hospital Health Network, the goal is to flip that script. Under the leadership of Dr. Kevin Banks, Executive Director of Precision Health and Pharmacogenomics, the network is turning their focus to identifying…
- By Charlie King, MGC, CGC
- Posted April 14, 2026
The Gene Scene: HPDL
Welcome to the Gene Scene! Each week, we will explore a gene from the ACMG Secondary Findings list—genes identified by the American College of Medical Genetics and Genomics as having clear, actionable health implications. These genes are included because they’re linked to serious but preventable or manageable conditions when identified early.…
- By Frankie Fann, MS, CGC
- Posted April 9, 2026
A Hidden Cancer, Found in Time: One Patient’s CARE Journey
Germline genetic testing, also known as hereditary cancer testing, can reveal inherited risks for certain cancers long before symptoms appear. For many patients, this knowledge opens the door to proactive screening and early detection, when cancers may be easier to treat. By routinely assessing which patients may be at increased hereditary risk,…
- By Grant Bonesteele, MS, CGC
- Posted April 7, 2026
The Gene Scene: GAA
Welcome to the Gene Scene! Each week, we will explore a gene from the ACMG Secondary Findings list—genes identified by the American College of Medical Genetics and Genomics as having clear, actionable health implications. These genes are included because they’re linked to serious but preventable or manageable conditions when identified early.…
- By Rachel Bluebond, MMSc, CGC
- Posted March 24, 2026
The Gene Scene: SMAD4
Welcome to the Gene Scene! Each week, we will explore a gene from the ACMG Secondary Findings list—genes identified by the American College of Medical Genetics and Genomics as having clear, actionable health implications. These genes are included because they’re linked to serious but preventable or manageable conditions when identified early.…
- By Haaniya Mallick, MS, CGC
- Posted March 17, 2026
The Gene Scene: CASQ2
Welcome to the Gene Scene! Each week, we will explore a gene from the ACMG Secondary Findings list—genes identified by the American College of Medical Genetics and Genomics as having clear, actionable health implications. These genes are included because they’re linked to serious but preventable or manageable conditions when identified early.…